YSYulu Song

Yulu Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yulu Song has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolite Relaxation Times at 3T From Birth to 7 Years

    by Saipavitra Murali-Manohar, Abdelrahman Gad, Zahra Shams, Gizeaddis L. Simegn, Yulu Song, Aaron T. Gudmundson, Helge J. Zo□Llner, Christopher W. Davies-Jenkins, Dunja Simicic, Vivek Yedavalli, et al.

    Purpose: With growing interest in pediatric MRS to understand the neurochemistry of brain development, it is essential to establish pediatric-specific metabolite T 1 and T 2 relaxation times for reliable quantification of metabolites. Furthermore, characterization of age-related changes in relaxation times may provide insight into developmental differences in tissue microstructure and cellular composition. Therefore, the goals of this study were two-fold: (1) to estimate metabolite T 1 and T 2 relaxation times in a pediatric cohort; and (2) to assess linear relationships between age and relaxation times. Methods: TI- and TE-series data were acquired from the bilateral thalamus in 20 and 25 participants aged between 0 and 7 years, respectively. Data were processed and modelled in Osprey 2.5.0. Metabolite T 1 and T 2 relaxation times of total N-acetylaspartate at 2.0 ppm (tNAA 2.0 ), total creatine at 3.0 ppm (tCr 3.0 ), total creatine at 3.9 ppm (tCr 3.9 ), total choline (tCho), myo-inositol (mI) and the combined glutamate and glutamine (Glx) were estimated by fitting the modelled signal amplitudes to TI-series inversion recovery signal and TE-series exponential decay equations, respectively. Linear relationships with age were tested for metabolite T 1 and T 2 relaxation times using Spearman correlations. Results: tNAA 2.0 and Glx showed significant changes in T 1 with age. tNAA 2.0 , tCr 3.0 , tCho and mI showed significant decrease in T 2 with age. Conclusion: Several metabolites showed significant changes in relaxation times with age in the thalamus region. Therefore, use of age-specific relaxation correction for pediatric studies using the linear equations provided is encouraged for reliable quantification of metabolites.

  • Open Access

    Age-related differences in neurometabolite concentrations during early infancy: A cross-sectional analysis of the HBCD Release 1.0

    by Saipavitra Murali-Manohar, Helge J. Zöllner, Christopher W. Davies-Jenkins, Aaron T. Gudmundson, Steve C. N. Hui, Yulu Song, Gizeaddis L. Simegn, Zahra Shams, Abdelrahman Gad, Borjan Gagoski, et al.

    Background: Developmental trajectories of low-concentration neurometabolites such as the neurotransmitter γ-aminobutyric acid (GABA), and the antioxidants glutathione (GSH) and ascorbate (Asc) across early infancy remain unexplored. Advances in spectral editing enabled the measurement of these key molecules together with high-concentration metabolites like N-acetylaspartate (NAA) and glutamate (Glu) in the HEALthy Brain and Child Development (HBCD) study, the largest longitudinal study of early brain development in the United States. Purpose: To determine the age-associated trajectories of 14 key neurometabolites during early infancy from a cross-sectional 1 H-MRS dataset. Materials and Methods: HBCD utilizes ISTHMUS, an integrated MRS sequence that includes both an unedited short-echo-time PRESS acquisition and an advanced 4-step Hadamard-encoded sequence, HERCULES to enable measurement of both high- and low-concentration metabolites. Metabolite quantification was carried out by the HBCD Data Coordinating Center (HDCC) using an automated Osprey pipeline, with data from 201 infants ages 0 – 10 weeks adjusted age included in the tabular imaging results in HBCD data release 1.0. After excluding preterm born infants and data with poor linewidth or model quality metric, we tested for linear associations with adjusted age for each metabolite. Results: Concentration estimates of total NAA (tNAA), total creatine (tCr) and glutamate (Glu) as well as the combined sum of glutamate and glutamine (Glx) significantly increased across ages 0 – 10 weeks, while myo-inositol (mI) decreased. GABA and GSH showed age-related trends, but did not reach significance. Levels of the lipid precursor phosphorylethanolamine (PE) and Asc are higher in the first months than established adult values. Conclusion: Multiple metabolites showed significant age-related changes during early infancy. While GABA and GSH did not, future work will establish whether the trends suggested here contribute to linear or non-linear patterns across the first years of life. Summary Statement: HBCD MRS Data Release 1.0 cross-sectional analysis of tabulated results shows significant changes of neurometabolite levels in the thalamus from birth to 10-week-old infants. Key Results: This study provides the first ever concentration level reports of multiple low-concentration metabolites such as GABA+, GSH, PE, Lac, Asc as well as their cross-sectional trajectory in early postnatal period of brain development.

  • Open Access

    Methylmalonic acid: a new target for Hadamard-edited MRS

    by Yulu Song, Tao Gong, Zahra Shams, Xiaoya Sun, Christopher W. Davies-Jenkins, Shuyuan Wang, Gizeaddis L. Simegn, Saipavitra Murali-Manohar, Abdelrahman Gad, Georg Oeltzschner, et al.

    Background: Methylmalonic acidemia (MMAemia) is a genetic metabolic disorder characterized by an accumulation of methylmalonic acid (MMA) and impaired energy metabolism leading to increased lactate (Lac). The signals of MMA (1.23 ppm) and Lac (1.33 ppm) overlap, making their separation using conventional MRS challenging. An MRS method to differentiate the two metabolites could enhance pathophysiological understanding and improve treatment monitoring - Hadamard-edited MRS has the potential to achieve this. Purpose: To develop a Hadamard-encoded J -difference editing approach for independent detection of MMA and Lac at 3T. Methods: A novel Hadamard-encoded editing scheme was implemented and evaluated with density-matrix simulations, phantom and in vivo experiments. The new four-step scheme uses frequency-selective editing pulses, applied at 3.2 ppm and 4.1 ppm to modulate the J -coupled methyl resonances of MMA and Lac, respectively. Hadamard combinations of the four sub-experiments yield the separate difference-edited spectra for each target metabolite. Results: Simulations and phantom experiments clearly illustrate the separated signals of MMA and Lac. In vivo validation experiments show a Lac signal (but no MMA) in a healthy infant, and both Lac and MMA (separated into their respective Hadamard-combination spectra) in a patient with MMAemia. Conclusion: Hadamard-encoded editing at 3T can separate MMA and Lac signals and shows promise for studying altered metabolism in patients with MMAemia.

  • Open Access

    Gradient Scheme Optimization for PRESS‐Localized Edited MRS Using Weighted Pathway Suppression

    by Gizeaddis L. Simegn, Zahra Shams, Saipavitra Murali‐Manohar, Dunja Simicic, Abdelrahman Gad, Yulu Song, Vivek Yedavalli, Christopher W. Davies‐Jenkins, Aaron T. Gudmundson, Helge J. Zöllner, et al.

    This study aimed to design and implement an optimized gradient scheme for PRESS‐localized edited magnetic resonance spectroscopy (MRS) to enhance suppression of out‐of‐voxel (OOV) artifacts. These artifacts, which originate from insufficient crushing of unwanted coherence transfer pathways (CTPs), are particularly challenging in editing schemes for metabolites like gamma‐aminobutyric acid and glutathione. To address this, a volume‐based likelihood model was developed to guide gradient scheme optimization, prioritizing suppression of CTPs based on likelihood. The volume‐based likelihood model for CTP weighting was integrated into a Dephasing optimization through coherence order pathway selection (DOTCOPS) gradient optimization. Using a genetic algorithm with a weighted dual‐penalty cost function, gradient schemes were optimized to maximize pathway‐specific suppression. Hardware and sequence constraints, maximum gradient amplitudes and delay durations respectively, informed the optimization. Validation of the optimized scheme was performed with simulations by calculating the k‐space crushing efficiency analytically with k‐space trajectory and in vivo using an edited MRS sequence in three brain regions (posterior cingulate cortex PCC, thalamus, and medial prefrontal cortex [mPFC]), with particular focus on OOV artifact reduction and spectral quality improvements. A three‐way Analysis of Variance was used to assess the significance level of OOV artifact reduction. The optimized gradient scheme demonstrated improved k‐space crushing efficiency (by an average of 197%). OOV artifacts were reduced in all brain regions, particularly in highly OOV‐susceptible regions (thalamus and mPFC). Improvements were most notable around 4.3 ppm with significant OOV artifact amplitude reductions ( p < 0.001). By using a volume‐based likelihood model for CTP prioritization, the optimized DOTCOPS scheme ensures robust and region‐agnostic performance in reducing OOV artifacts.


  • Myo‐Inositol Levels in the Dorsal Anterior Cingulate Cortex Are Associated With Anxiety‐to‐Eat in Anorexia Nervosa

    by Yulu Song, Sarah H. Guo, Christopher W. Davies‐Jenkins, Angela S. Guarda, Richard A. E. Edden, Kimberly R. Smith

    While substantial research has focused on general anxiety in anorexia nervosa (AN), eating‐related anxiety is insufficiently understood and less is known about its underlying neurobiological mechanisms. We integrated behavioral and magnetic resonance spectroscopy (MRS) methods to characterize anxiety‐to‐eat and to identify its neurometabolic correlates in females with AN ( n = 16) and in healthy weight females without a lifetime history of an eating disorder (healthy controls; HC; n = 16). Anxiety‐to‐eat was assessed via a computer‐based task in which participants rated their level of anxiety‐to‐eat on a visual analogue scale in response to images of a standard serving of higher (HED) and lower energy density (LED) foods. Levels of nine neurometabolites in the dorsal anterior cingulate cortex (dACC), a brain region putatively involved in modulating anxiety‐related responses, were assessed using edited MRS. The AN group reported greater anxiety‐to‐eat in response to HED and LED foods relative to the HC group. Both groups reported greater anxiety‐to‐eat in response to HED relative to LED foods. The neurometabolite myo‐inositol (myo‐I), a carbocyclic sugar and precursor molecule to phosphatidyl‐inositol species in second‐messenger systems shown to be dysregulated in AN (e.g., adrenergic, serotonergic, glutamatergic), was lower in the dACC in AN relative to HC. Additionally, in the AN group only, myo‐I levels negatively predicted anxiety‐to‐eat in response to HED but not LED foods independent of body mass index, duration of illness, and general anxiety. These findings raise the possibility that lower myo‐I in the dACC and its relationship with anxiety‐to‐eat responses in AN reflect a distinct biological and behavioral phenotype of AN pathology. To understand the clinical implications of these findings, future studies should investigate the effect of treatment on myo‐I levels or directly manipulate myo‐I levels in the diet and assess resulting changes in anxiety‐to‐eat.


  • Open Access

    Gradient scheme optimization for PRESS-localized edited MRS using weighted pathway suppression

    by Gizeaddis L. Simegn, Zahra Shams, Saipavitra Murali-Manohar, Dunja Simicic, Abdelrahman Gad, Yulu Song, Vivek Yedavalli, Christopher W. Davies-Jenkins, Aaron T. Gudmundson, Helge J. Zöllner, et al.

    This study aimed to design and implement an optimized gradient scheme for PRESS-localized edited magnetic resonance spectroscopy (MRS) to enhance suppression of out-of-voxel (OOV) artifacts. These artifacts, which originate from insufficient crushing of unwanted coherence transfer pathways (CTPs), are particularly challenging in editing schemes for metabolites like gamma-aminobutyric acid and glutathione. To address this, a volume-based likelihood model was developed to guide gradient scheme optimization, prioritizing suppression of CTPs based on likelihood. A volume-based likelihood model for CTP weighting was integrated into a Dephasing optimization through coherence order pathway selection (DOTCOPS) gradient optimization. Using a genetic algorithm with a new dual-penalty cost function, gradient schemes were optimized to maximize pathway-specific suppression. Hardware and sequence constraints, maximum gradient amplitudes and delay durations respectively, informed the optimization. Validation of the optimized scheme was performed with simulations by calculating the k-space crushing efficiency analytically with k-space trajectory. and in vivo using an edited MRS sequence in three brain regions (posterior cingulate cortex PCC, thalamus, and medial prefrontal cortex (mPFC)), with particular focus on OOV artifact reduction and spectral quality improvements. A three-way Analysis of Variance was used to assess the significance level of OOV artifact reduction. The optimized gradient scheme demonstrated improved k-space crushing efficiency (by an average of 197%). OOV artifacts were reduced in all brain regions, particularly in highly OOV-susceptible regions (thalamus and mPFC). Improvements were most notable around 4.3 ppm with significant OOV artifact amplitude reductions (p < 0.001). By using a volume-based likelihood model for CTP prioritization, the optimized DOTCOPS scheme ensures robust and region-agnostic performance in reducing OOV artifacts.

  • Open Access

    Age dependency of neurometabolite T1relaxation times

    by Saipavitra Murali-Manohar, Helge J. Zoellner, Kathleen E. Hupfeld, Yulu Song, Emily E. Carter, Vivek Yedavalli, Steve C. N. Hui, Dunja Simicic, Aaron T. Gudmundson, Gizeaddis Lamesgin Simegn, et al.

    Purpose: To measure T1relaxation times of metabolites at 3T in a healthy aging population and investigate age dependence.Methods: A cohort of 101 healthy adults were recruited with approximately 10 male and 10 female participants in each ‘decade’ band: 18-29, 30-39, 40-49, 50-59, and 60+ years old. Inversion-recovery PRESS data (TE/TR: 30/2000 ms) were acquired at 8 inversion times (TIs) (300, 400, 511, 637, 780, 947, 1148 and 1400 ms) from voxels in white-matter-rich centrum semiovale (CSO) and gray-matter-rich posterior cingulate cortex (PCC). Modeling of TI-series spectra was performed in Osprey 2.5.0. Quantified metabolite amplitudes for total N-acetylaspartate (tNAA2.0), total creatine at 3.0 ppm (tCr3.0) and 3.9 ppm (tCr3.9), total choline (tCho), myo-inositol (mI), and the sum of glutamine and glutamate (Glx) were modeled to calculate T1relaxation times of metabolites.Results: T1relaxation times of tNAA2.0in CSO and tNAA2.0, tCr3.0, mI and Glx in PCC decreased with age. These correlations remained significant when controlling for cortical atrophy. T1relaxation times were significantly different between PCC and CSO for all metabolites except tCr3.0. We also propose linear models for predicting metabolite T1s at 3T to be used in future aging studies.Conclusion: Metabolite T1relaxation times change significantly with age, an effect that will be important to consider for accurate quantitative MRS, particularly in studies of aging.


  • Open Access

    A Water Relaxation Atlas for Age- and Region-specific Metabolite Concentration Correction

    by Gizeaddis Lamesgin Simegn, Yulu Song, Saipavitra Murali-Manohar, Helge J. Zöllner, Christopher W. Davies-Jenkins, Dunja Simičić, Kathleen E. Hupfeld, Aaron T. Gudmundson, Emlyn Musaka, Emily Carter, et al.

    Metabolite concentration estimates from Magnetic Resonance Spectroscopy (MRS) are typically quantified using water referencing, correcting for relaxation-time differences between metabolites and water. One common approach is to correct the water reference signal for differential relaxation within three tissue compartments (gray matter, white matter, and cerebrospinal fluid) using fixed literature values. However, water relaxation times ( T 1 and T 2 ) vary between brain locations, in pathology, and with age. MRS studies, even those measuring metabolite levels across the lifespan, often ignore these effects, because of a lack of reference data. The purpose of this study is to develop a water relaxometry atlas and to integrate location- and age-appropriate relaxation values into the MRS analysis workflow. 101 volunteers (51 men, 50 women; ∼10 male and 10 female participants per decade (from the 20s to 60s), were recruited. T 1 -weighted MPRAGE images ((1-mm) 3 isotropic resolution) were acquired. Whole-brain water T 1 and T 2 measurements were made with DESPOT ((1.4 mm) 3 isotropic resolution). T 1 and T 2 maps were registered to the JHU MNI-SS/EVE atlas using affine and LDDMM transformation. The atlas’s 268 parcels were reduced to 130 by combining homologous parcels. Mean T 1 and T 2 values were calculated for each parcel in each subject. Linear models of T 1 and T 2 as functions of age were computed, using age – 30 as the predictor. Reference atlases of “age-30-intercept” and age-slope for T 1 and T 2 were generated. The atlas-based workflow was integrated into Osprey, which co-registers MRS voxels to the atlas and calculates location- and age-appropriate water relaxation parameters for quantification. The water relaxation aging atlas revealed significant regional and tissue differences in water relaxation behavior across adulthood. Using location- and subject-appropriate reference values in the MRS analysis workflow removes a current methodological limitation and is expected to reduce quantification biases associated with water-referenced tissue correction, especially for studies of aging.

  • GABA‐edited MEGA‐PRESS at 3 T: Does a measured macromolecule background improve linear combination modeling?

    by Christopher W. Davies‐Jenkins, Helge J. Zöllner, Dunja Simicic, Steve C. N. Hui, Yulu Song, Kathleen E. Hupfeld, James J. Prisciandaro, Richard A. E. Edden, Georg Oeltzschner

    Purpose: The J‐difference edited γ‐aminobutyric acid (GABA) signal is contaminated by other co‐edited signals—the largest of which originates from co‐edited macromolecules (MMs)—and is consequently often reported as “GABA+.” MM signals are broader and less well‐characterized than the metabolites, and are commonly approximated using a Gaussian model parameterization. Experimentally measured MM signals are a consensus‐recommended alternative to parameterized modeling; however, they are relatively under‐studied in the context of edited MRS.Methods: To address this limitation in the literature, we have acquired GABA‐edited MEGA‐PRESS data with pre‐inversion to null metabolite signals in 13 healthy controls. An experimental MM basis function was derived from the mean across subjects. We further derived a new parameterization of the MM signals from the experimental data, using multiple Gaussians to accurately represent their observed asymmetry. The previous single‐Gaussian parameterization, mean experimental MM spectrum and new multi‐Gaussian parameterization were compared in a three‐way analysis of a public MEGA‐PRESS dataset of 61 healthy participants.Results: Both the experimental MMs and the multi‐Gaussian parameterization exhibited reduced fit residuals compared to the single‐Gaussian approach (p = 0.034 and p = 0.031, respectively), suggesting they better represent the underlying data than the single‐Gaussian parameterization. Furthermore, both experimentally derived models estimated larger MM fractional contribution to the GABA+ signal for the experimental MMs (58%) and multi‐Gaussian parameterization (58%), compared to the single‐Gaussian approach (50%).Conclusions: Our results indicate that single‐Gaussian parameterization of edited MM signals is insufficient and that both experimentally derived GABA+ spectra and their parameterized replicas improve the modeling of GABA+ spectra.


  • Open Access

    Myo-inositol in the Dorsal Anterior Cingulate Cortex is Associated with Anxiety-to-Eat in Anorexia Nervosa

    by Yulu Song, Sarah H. Guo, Christopher W. Davies-Jenkins, Angela Guarda, Richard A.E. Edden, Kimberly R. Smith

    Anorexia nervosa (AN) is a mental and behavioral health condition characterized by an intense fear of body weight or fat gain, restriction of food intake resulting in low body weight, and distorted body image. Substantial research has focused on general anxiety in AN, but less is known about eating-related anxiety and its underlying neurobiological mechanisms. We sought to characterize anxiety-to-eat in AN and to examine neurometabolite levels in the dorsal anterior cingulate cortex (dACC), a brain region putatively involved in modulating anxiety-related responses, using edited magnetic resonance spectroscopy. Sixteen women hospitalized with AN and 16 women of healthy weight without a lifetime history of an eating disorder (healthy controls; HC) completed a computer-based behavioral task assessing anxiety-to-eat in response to images of higher (HED) and lower energy density (LED) foods. The AN group reported greater anxiety to eat HED and LED foods relative to the HC group. Both groups reported greater anxiety to eat HED foods relative to LED foods. The neurometabolite myo-inositol (myo-I) was lower in the dACC in AN relative to HC. In the AN group only, myo-I levels negatively predicted anxiety to eat HED but not LED foods and was independent of body mass index, duration of illness, and general anxiety. These findings provide new insight into the clinically challenging feature of eating-related anxiety in AN, and indicate potential for myo-I levels in the dACC to serve as a novel biomarker of illness severity or therapeutic target in individuals vulnerable to AN.